112
Views
10
CrossRef citations to date
0
Altmetric
Miscellaneous

The inhibitory effect of bisphosphonates on glucocorticoid‐induced RANKL expression in human cells

, &
Pages 480-484 | Received 09 Jun 2004, Accepted 17 Apr 2005, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrew W. Barone, Gabriela Fernandes & Rosemary Dziak. (2018) Effects of alendronate and interferon-γ on bone cancer cells in vitro. Cogent Biology 4:1.
Read now
C. Book, M. Karlsson, K. Åkesson & L. Jacobsson. (2008) Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scandinavian Journal of Rheumatology 37:4, pages 248-254.
Read now

Articles from other publishers (8)

Roberta Sanguineti, Alessandra Puddu, François Mach, Fabrizio Montecucco & Giorgio Luciano Viviani. (2014) Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis. Mediators of Inflammation 2014, pages 1-9.
Crossref
Masakazu Nagashima, Hiroshi Takahashi, Kenichi Shimane, Yuichi Nagase & Koichi Wauke. (2012) Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates. Arthritis Research & Therapy 14:5, pages R224.
Crossref
Behnam Eslami, Shuanhu Zhou, Inge Van Eekeren, Meryl S. LeBoff & Julie Glowacki. (2011) Reduced Osteoclastogenesis and RANKL Expression in Marrow from Women Taking Alendronate. Calcified Tissue International 88:4, pages 272-280.
Crossref
Maria Felicia Faienza, Giacomina Brunetti, Silvia Colucci, Laura Piacente, Maria Ciccarelli, Lucia Giordani, Giovanni Carlo Del Vecchio, Massimo D'Amore, Livia Albanese, Luciano Cavallo & Maria Grano. (2009) Osteoclastogenesis in Children with 21-Hydroxylase Deficiency on Long-Term Glucocorticoid Therapy: The Role of Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Imbalance. The Journal of Clinical Endocrinology & Metabolism 94:7, pages 2269-2276.
Crossref
Roger H. Weenig. (2008) Pathogenesis of calciphylaxis: Hans Selye to nuclear factor κ-B. Journal of the American Academy of Dermatology 58:3, pages 458-471.
Crossref
Xiaozhe Han, Toshihisa Kawai & Martin A. Taubman. (2007) Interference with immune-cell-mediated bone resorption in periodontal disease. Periodontology 2000 45:1, pages 76-94.
Crossref
María Pilar Aguado Acín. (2007) Osteoporosis inducida por glucocorticoides: ¿qué hay de nuevo?. Reumatología Clínica 3, pages S3-S8.
Crossref
Anne M. Barger, Timothy M. Fan, Louis‐Philippe de Lorimier, Ian T. Sprandel & Kristen O'Dell‐Anderson. (2008) Expression of Receptor Activator of Nuclear Factor k‐B Ligand (RANKL) in Neoplasms of Dogs and Cats. Journal of Veterinary Internal Medicine 21:1, pages 133-140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.